Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smilon in Depression Patients With Pain
NCT01119924Phase 4Completed
- Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Start
- Dec 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic pain syndrome (CPS) and major depressive disorder (MDD) comparing Mirtazapine with Placebo (2 arms). Primary endpoint: Visual Analog Scale for Pain Intensity at 8 weeks. Started Dec 2009; status: completed.
02
Drugs
mirtazapine
03
Conditions
chronic pain syndrome (CPS)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01119924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119924.